Comparison of hprt and lacl mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminoflourene-treated Big Blue® rats

被引:14
作者
Chen, T
Mittelstaedt, RA
Aidoo, A
Hamilton, LP
Beland, FA
Casciano, DA
Heflich, RH
机构
[1] Natl Ctr Toxicol Res, Div Genet & Reprod Toxicol, Jefferson, AR 72079 USA
[2] Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA
[3] Natl Ctr Toxicol Res, Off Director, Jefferson, AR 72079 USA
关键词
P-32-postlabeling; liver; spleen lymphocytes; bone marrow; transgene;
D O I
10.1002/em.1028
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
N-Hydroxy-2-acetylaminofluorene (N-OH-AAF) is the proximate carcinogenic metabolite of the powerful rat liver carcinogen 2-acetylaminofluorene. In this study, transgenic Big Blue(R) rats were used to examine the relationship between in vivo mutagenicity and DNA adduct formation by N-OH-AAF in the target liver compared with that in nontarget tissues. Male rats were given one, two, or four doses of 25 mg N-OH-AAF/kg body weight by i.p. injection at 4-day intervals, and groups of treated and control rats were euthanized up to 10 weeks after beginning the dosing. Mutant frequencies were measured in the spleen lymphocyte hprt gene, and loci mutant frequencies were determined in the liver and spleen lymphocytes. At 6 weeks after beginning the dosing, the hprt mutant frequency in spleen lymphocytes from the four-dose group was 16.5 x 10(-6) compared with 3.2 x 10(-6) in control animals. Also at 6 weeks, rats given one, two, or four doses of N-OH-AAF had loci mutant frequencies in the liver of 97.6, 155.6, and 406.8 x 10(-6), respectively, compared with a control frequency of 25.7 x 10(-6) rats given four doses had loci mutant frequencies in spleen lymphocytes of 55.8 x 10(-6) compared with a control Frequency of 20.4 x 10(-6). Additional rats were evaluated for DNA adduct formation in the liver, spleen lymphocytes, and bone marrow by P-32-postlabeling. Adduct analysis was conducted 1 day after one, two, and four treatments with N-OH-AAF, 5 days after one treatment, and 9 days after two treatments. N-(Deoxyguanosin-8-yl)-2-aminofluorene was the major DNA adduct identified in all the tissues examined. Adduct concentrations increased with total dose to maximum values in samples token 1 day after two doses, and remained essentially the same after Four doses. In samples taken after Four doses, adduct levels were 103, 28, and 7 fmol/mug of DNA in liver, spleen lymphocytes, and bone marrow, respectively. The results indicate that the extent of both DNA adduct formation and mutant induction correlates with the organ specificity For N-OH-AAF carcinogenesis in the rat. Environ. Mol. Mutagen. 37:195-202, 2001. Published 2001 Wiley-Liss, Inc.dagger
引用
收藏
页码:195 / 202
页数:8
相关论文
共 50 条
[1]   THE EFFECT OF TIME AFTER TREATMENT, TREATMENT SCHEDULE AND ANIMAL AGE ON THE FREQUENCY OF 6-THIOGUANINE-RESISTANT LYMPHOCYTE-T INDUCED IN FISCHER-344 RATS BY N-ETHYL-N-NITROSOUREA [J].
AIDOO, A ;
LYNCOOK, LE ;
HEFLICH, RH ;
GEORGE, EC ;
CASCIANO, DA .
MUTATION RESEARCH, 1993, 298 (03) :169-178
[2]   INDUCTION OF 6-THIOGUANINE-RESISTANT LYMPHOCYTES IN FISCHER-344 RATS FOLLOWING INVIVO EXPOSURE TO N-ETHYL-N-NITROSOUREA AND CYCLOPHOSPHAMIDE [J].
AIDOO, A ;
LYNCOOK, LE ;
MITTELSTAEDT, RA ;
HEFLICH, RH ;
CASCIANO, DA .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1991, 17 (03) :141-151
[3]   Development and utilization of the rat lymphocyte hprt mutation assay [J].
Aidoo, A ;
Morris, SM ;
Casciano, DA .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 387 (02) :69-88
[4]   HYBRIDIZATION OF NUCLEAR MATRIX ATTACHED DEOXYRIBONUCLEIC-ACID FRAGMENTS [J].
BASLER, J ;
HASTIE, ND ;
PIETRAS, D ;
MATSUI, SI ;
SANDBERG, AA ;
BEREZNEY, R .
BIOCHEMISTRY, 1981, 20 (24) :6921-6929
[5]  
Beland F. A., 1990, CHEM CARCINOGENESIS, P267, DOI DOI 10.1007/978-3-642-74775-5_8
[6]   Hprt lymphocyte mutant frequency in relation to DNA adduct formation in rats fed the hepatocarcinogen 2-acetylaminofluorene [J].
Beland, FA ;
Fullerton, NF ;
Smith, BA ;
Mittelstaedt, RA ;
Heflich, RH .
CANCER LETTERS, 1999, 143 (02) :249-255
[7]   FORMATION AND PERSISTENCE OF ARYLAMINE DNA ADDUCTS INVIVO [J].
BELAND, FA ;
KADLUBAR, FF .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1985, 62 (OCT) :19-30
[8]  
BELAND FA, 1982, CANCER RES, V42, P1348
[9]  
BELAND FA, 1980, CANCER RES, V40, P834
[10]   RAPID ISOLATION, HYDROLYSIS AND CHROMATOGRAPHY OF FORMALDEHYDE-MODIFIED DNA [J].
BELAND, FA ;
FULLERTON, NF ;
HEFLICH, RH .
JOURNAL OF CHROMATOGRAPHY, 1984, 308 (JUN) :121-131